You just read:

Impax Receives Positive CHMP Opinion for NUMIENT™ (Levodopa and Carbidopa) Modified-Release Capsules for the Symptomatic Treatment of Adult Patients with Parkinson's disease

News provided by

Impax Laboratories, Inc.

Sep 25, 2015, 09:15 ET